Showing results (1831-1840 of 3,871) with videos related to
Sort By:
Pageof 388
Cancer Biology & Therapy|May 5, 2020
Copy number variation of ubiquitin- specific proteases genes in blood leukocytes and colorectal cancerTian Tian, Haoran Bi, Yupeng Liu, et al.Cancer Biology & Therapy|February 2, 2023
Integrating DOI in T classification improves the predictive performance of laryngeal cancer stagingXueying Wang, Kui Cao, Erliang Guo, et al.Cancer Biology & Therapy|September 19, 2012
Isolated central nervous system progression on Crizotinib: an Achilles heel of non-small cell lung cancer with EML4-ALK translocation?Stephen G Chun, Kevin S Choe, Puneeth Iyengar, et al.Cancer Biology & Therapy|November 2, 2012
Small molecule kinase inhibitors block the ZAK-dependent inflammatory effects of doxorubicinJohn Wong, Logan B Smith, Eli A Magun, et al.Cancer Biology & Therapy|November 2, 2012
Overexpression of cyclin B1 antagonizes chemotherapeutic-induced apoptosis through PTEN/Akt pathway in human esophageal squamous cell carcinoma cellsYunwei Ou, Liying Ma, Ling Ma, et al.Cancer Biology & Therapy|November 2, 2012
Clinical usefulness of human epidermal growth factor receptor-2 extracellular domain as a biomarker for monitoring cancer status and predicting the therapeutic efficacy in breast cancerKeiichi Kontani, Noriyuki Kuroda, Shin-ichiro Hashimoto, et al.Cancer Biology & Therapy|November 2, 2012
Adaptation of a chemosensitivity assay to accurately assess pemetrexed in ex vivo cultures of lung cancerSarah L Suchy, Rodney J Landreneau, Matthew J Schuchert, et al.Cancer Biology & Therapy|November 2, 2012
Treatment-induced secretion of WNT16B promotes tumor growth and acquired resistance to chemotherapy: implications for potential use of inhibitors in cancer treatmentLinda M Johnson, Douglas K Price, William D FiggCancer Biology & Therapy|August 14, 2020
Examining HSD3B1 as a possible biomarker to detect prostate cancer patients who are likely to progress on ADTWhitney F Handy, Keith T Schmidt, Douglas K Price, et al.Cancer Biology & Therapy|November 16, 2012
Rapalogs in cancer prevention: anti-aging or anticancer?Mikhail V BlagosklonnyPageof 388